JPWO2021153649A1 - - Google Patents

Info

Publication number
JPWO2021153649A1
JPWO2021153649A1 JP2021574091A JP2021574091A JPWO2021153649A1 JP WO2021153649 A1 JPWO2021153649 A1 JP WO2021153649A1 JP 2021574091 A JP2021574091 A JP 2021574091A JP 2021574091 A JP2021574091 A JP 2021574091A JP WO2021153649 A1 JPWO2021153649 A1 JP WO2021153649A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021574091A
Other versions
JP7347767B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021153649A1 publication Critical patent/JPWO2021153649A1/ja
Application granted granted Critical
Publication of JP7347767B2 publication Critical patent/JP7347767B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2021574091A 2020-01-31 2021-01-28 造血幹細胞移植後の合併症リスクの検出方法、予測診断薬及びキット Active JP7347767B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020015285 2020-01-31
JP2020015285 2020-01-31
PCT/JP2021/002963 WO2021153649A1 (ja) 2020-01-31 2021-01-28 造血幹細胞移植後の合併症リスクの検出方法、予測診断薬及びキット

Publications (2)

Publication Number Publication Date
JPWO2021153649A1 true JPWO2021153649A1 (ja) 2021-08-05
JP7347767B2 JP7347767B2 (ja) 2023-09-20

Family

ID=77079855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021574091A Active JP7347767B2 (ja) 2020-01-31 2021-01-28 造血幹細胞移植後の合併症リスクの検出方法、予測診断薬及びキット

Country Status (2)

Country Link
JP (1) JP7347767B2 (ja)
WO (1) WO2021153649A1 (ja)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016100745A2 (en) * 2014-12-19 2016-06-23 Children's Hospital Medical Center Methods and compositions related to transplant-associated thrombotic microangiopathy
JP2016528235A (ja) * 2013-08-07 2016-09-15 アレクシオン ファーマシューティカルズ， インコーポレイテッド 非典型溶血性尿毒症症候群のバイオマーカータンパク質

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016528235A (ja) * 2013-08-07 2016-09-15 アレクシオン ファーマシューティカルズ， インコーポレイテッド 非典型溶血性尿毒症症候群のバイオマーカータンパク質
WO2016100745A2 (en) * 2014-12-19 2016-06-23 Children's Hospital Medical Center Methods and compositions related to transplant-associated thrombotic microangiopathy

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SARTAIN, SARAH E. ET AL.: "Patients with Transplantation-Associated Thrombotic Microangiopathy Demonstrate Elevated Levels of B", BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, vol. 25(3)Supplement, JPN6021009981, 2019, pages 150 - 151, ISSN: 0004989676 *
SARTAIN, SARAH ET AL.: "The alternative complement pathway activation product Ba as a marker for transplant-associated throm", PEDIATRIC BLOOD & CANCER, JPN6021009980, 27 November 2019 (2019-11-27), ISSN: 0004989675 *

Also Published As

Publication number Publication date
JP7347767B2 (ja) 2023-09-20
WO2021153649A1 (ja) 2021-08-05

Similar Documents

Publication Publication Date Title
BR112023005462A2 (ja)
BR112023012656A2 (ja)
BR112021014123A2 (ja)
BR112022009896A2 (ja)
BR112023009656A2 (ja)
BR112022024743A2 (ja)
BR112023006729A2 (ja)
BR102021018859A2 (ja)
BR102021015500A2 (ja)
BR102021007058A2 (ja)
BR102020022030A2 (ja)
BR112023011738A2 (ja)
BR112023016292A2 (ja)
BR112023004146A2 (ja)
BR112023011539A2 (ja)
BR112023011610A2 (ja)
BR112023008976A2 (ja)
BR102021020147A2 (ja)
BR102021018926A2 (ja)
BR102021018167A2 (ja)
BR102021017576A2 (ja)
BR102021016837A2 (ja)
BR102021016551A2 (ja)
BR102021016375A2 (ja)
BR102021016176A2 (ja)

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220727

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220727

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230412

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230614

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230822

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230830

R150 Certificate of patent or registration of utility model

Ref document number: 7347767

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150